Business
CVS reports health services, health care benefits, and pharmacy and consumer wellness rows.
CVS grew revenue and FCF, but earnings fell sharply.
The read at a glance✓ Audited against SEC data
- Business mix — Health services, benefits, pharmacyNote
- Revenue — $402.07B, +7.8%OK
- Net income — $1.77B, -61.7%Watch
- FCF — $7.81B, +23.4%OK
- Buybacks — $0.00, -100.0%Note
- Altman/Beneish/EQ — Grey Z; M no flag; EQ safeNote
- Insiders — 0 purchases / 2 salesWatch
Where the revenue comes from
Fiscal 2025, as CVS HEALTH Corp reports it. History and quarterly detail are in the app.
- Products$249.9B
- Services$15.2B
Leadership changes
From CVS HEALTH Corp's own filings, the day they're filed.
- Teresa Heitsenrether · President and Chief · appointmenteff. 2026-11-18
- Larry M. Robbins · Directors · departureeff. 2026-08-13
- Brian O. Newman · President · appointmenteff. 2025-05-12
Latest filings
- 8-K · Company announcement2026-08-17
- 10-Q · Quarterly report2026-08-05
- 8-K · Company announcement2026-08-05
- 8-K · Company announcement2026-05-18
- 8-K · Company announcement2026-05-06
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- Main tension🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about CVS HEALTH Corp, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.